HEC-016
/ Shenzhen Fifth People's Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 14, 2022
An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects
(clinicaltrials.gov)
- P1 | N=18 | Recruiting | Sponsor: Shenzhen Fifth People's Hospital
CAR T-Cell Therapy • New P1 trial • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Gastrointestinal Cancer • Hepatology • Oncology • Pancreatic Cancer • Solid Tumor • CLDN18 • HER-2
1 to 1
Of
1
Go to page
1